SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3/A - Initial statement of beneficial ownership of securities: [Amend]
SEC Accession No. 0001140361-17-028009
Filing Date
2017-07-17
Accepted
2017-07-17 18:14:32
Documents
1
Period of Report
2017-06-14

Document Format Files

Seq Description Document Type Size
1 FORM 3/A doc1.html 3/A  
1 FORM 3/A doc1.xml 3/A 3656
  Complete submission text file 0001140361-17-028009.txt   5222
Mailing Address 2150 ST. ELZEAR BLVD. WEST LAVAL QUEBEC A8 H7L 4A8
Business Address 2150 ST. ELZEAR BLVD. WEST LAVAL QUEBEC A8 H7L 4A8 514-744-6792
Valeant Pharmaceuticals International, Inc. (Issuer) CIK: 0000885590 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A8 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 1251 AVENUE OF THE AMERICAS NEW YORK NY 10020
Business Address
Paulson John (Reporting) CIK: 0001394923 (see all company filings)

Type: 3/A | Act: 34 | File No.: 001-14956 | Film No.: 17968284